Companies: 10,795·Total market cap: $144.5T
LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc.

LMATNASDAQHealthcare● Active
$94.32
$-0.16(-0.17%)
Market Cap$2.2B
P/E Ratio
52W High$118.01
52W Low$79.01
Overview

LeMaitre Vascular, Inc. (LMAT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LMAT · as of Jun 8, 2026

Key Statistics

EPS (TTM)$2.76lmat eps ttm · lmat earnings per shareEarnings history
PE Ratio (TTM)34.2×lmat pe ratio ttm · lmat price to earningsPE Ratio deep dive
Revenue (TTM)$256.3Mlmat revenue ttm · lmat annual revenueFull revenue history
Dividend Yield0.90%does lmat pay dividends · lmat dividend yieldDividend history
Shares Outstanding22.6Mlmat shares outstanding · lmat floatShares outstanding history
Next EarningsAug 4, 2026Est.lmat earnings date · lmat next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$249.6M▲ +13.53% YoY
202320242025
lemaitre vascular, inc. revenue · lmat revenue 2025
FY 2025Net Income$57.7M▲ +31.10% YoY
202320242025
lemaitre vascular, inc. net income · lmat profit 2025
FY 2025EPS$2.55▲ +30.10% YoY
202320242025
lmat eps · lemaitre vascular, inc. earnings per share 2025
TTM:Revenue: $256.3MNet Income: $62.4MEPS: $2.76View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy20 analystsis lmat a buy · lmat analyst rating
Strong Buy
0
Buy
14
Hold
6
Sell
0
Strong Sell
0
12-Month Price Target
$120.00Low
$94.32Current
$127.50Avg Target35.18% upside
$135.00High
lmat price target · lmat 12 month forecast

Total: 20 · Buy rate: 70.0%

The LMAT analyst consensus is Buy, based on ratings from 20 Wall Street analysts over the past 3 months. The average 12-month price target is $127.50, representing +35.18% upside from the current price of $94.32.

Stock Performance

Full History
1D+0.02%
1W+3.19%
1M-12.45%
3M-12.00%
YTD+16.52%
1Y+13.42%
5Y+76.54%

About LeMaitre Vascular, Inc.

CEOGeorge W. LeMaitre
IPO DateOct 19, 2006
Employees651
CountryUS

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic cath…

what is lemaitre vascular, inc. · lmat stock overview · lemaitre vascular, inc. company profile · who is lemaitre vascular, inc. ceo · lmat NASDAQ · lemaitre vascular, inc. headquarters · lemaitre vascular, inc. business segments

About Stock Overview & Key Data

LeMaitre Vascular, Inc. (LMAT) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Oct 19, 2006. As of the latest trading session, LMAT stock price is $94.32, with a market capitalization of $2.2B. The stock has returned +13.42% over the past 12 months and +16.52% year-to-date.

According to 20 Wall Street analysts, the consensus rating for LeMaitre Vascular, Inc. stock is Buy, with an average 12-month price target of $127.50. In fiscal year 2025, LeMaitre Vascular, Inc. reported revenue of $249.6M and net income of $57.7M. For detailed data — including LeMaitre Vascular, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, LeMaitre Vascular, Inc. (LMAT) stock price is $94.32. The stock is traded on NASDAQ under the ticker symbol LMAT. The 52-week range is $79.01 – $118.01.

LMAT stock priceLMAT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice